You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Iran

Aug 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health sustains healthy growth in 2011 but at a slower pace

With increasing disposable incomes and improvements in the standard of living, demand for healthcare products enjoyed impressive growth in recent years. With the emergence of multinationals and their premium quality, domestic suppliers have had to improve the quality and packaging of their products to prevent a loss of market share. However, some cultural trends, such as self-medication and lack of strong supervision of UTC sales, had a negative effect on the sales of OTC items. The rate of growth was higher for some categories, such as vitamins and dietary supplements, which had a lower starting base and greater potential.

Economic and political factors threaten both importers and manufacturers

The main event in 2011 was the sudden decline of the national currency where US$1which had been equivalent to IRR11,000, suddenly dropped to IRR19,000. This was a shock for importers (who had to pay in US$ to multinationals) and domestic manufacturers (who had to pay in US$ to their suppliers of raw materials). On the other hand, the Iranian government continued to refuse to pay its debts to pharmaceutical companies which put many of them at risk of bankruptcy. Finally, international sanctions on Iranian nuclear ambitions became much tighter which even made financial transactions impossible for many importers.

Increasing availability of imported vitamins and dietary supplements

The impressive performance of Poura Teb Medical & Pharmaceutical, which is the leading importer of vitamins and dietary supplements from well known multinationals such as Nature Made, highlights the growing popularity of foreign products in this area amongst Iranian consumers. Domestic suppliers which had previously not had to face any significant competition are increasingly being forced to only concentrate on consumer health where value sales are far lower than those within vitamins and dietary supplements. Due to major investment in advertising by multinationals and the much higher quality of the brands of such companies, domestic manufacturers are finding it increasingly difficult to compete and are therefore losing market share.

Distribution mainly only allowed through chemists/pharmacies

The distribution of most consumer health products in Iran is only allowed through chemists/pharmacies, due to the strict regulations set by the Ministry of Health and Hygiene. There are more than 7,000 chemists/pharmacies in Iran, scattered all around the country. However, a number of Western medicinal products are smuggled into Iran on a regular basis and it is possible to find various products, even rare ones, outside chemists/pharmacies outlets. Naser Khosro Street in Tehran is one of the most popular locations for the sale of contraband products. There is very little control over such illegal activities in Iran although the price of rare medicinal products in this location is very high. In general, due to the very low unit prices of medicines in Iran with most products being subsidised by the government, chemists/pharmacies receive more revenue from selling cosmetics and toiletries and household care products.

Reduced subsidies to have a significant impact on unit price and consumption

The Iranian government has started a programme to eliminate subsidies on major commodities, including pharmaceutical products. These subsidies are being replaced by direct payments. Although OTC health care products are still not included in the programme, this will not be the case for future phases. When subsidies for these products are reduced or eliminated, the Iranian market will face a sudden increase in unit price which will discourage use of consumer health products.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Iran with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Iran, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Iran for free:

The Consumer Health in Iran market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Iran?
  • What are the major brands in Iran?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Iran - Industry Overview

EXECUTIVE SUMMARY

Consumer health sustains healthy growth in 2011 but at a slower pace

Economic and political factors threaten both importers and manufacturers

Increasing availability of imported vitamins and dietary supplements

Distribution mainly only allowed through chemists/pharmacies

Reduced subsidies to have a significant impact on unit price and consumption

KEY TRENDS AND DEVELOPMENTS

Major turmoil for the Iranian economy

Huge young Iranian population remains the main growth driver

Pharmacies remain the main distribution channel

Strong influence of self-medication and UTC consumption

Brand awareness of OTC remains limited, unlike VDS

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Iran - Company Profiles

Darou Pakhsh Pharmaceutical MFG Co in Consumer Health (Iran)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Darou Pakhsh Pharmaceutical MFG: Competitive Position 2011

Dr Abidi Pharmaceutical Co in Consumer Health (Iran)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Dr Abidi Pharmaceutical Co: Competitive Position 2011

Poura Teb Medical & Pharmaceutical Co in Consumer Health (Iran)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Poura Teb Medical and Pharmaceutical Co: Competitive Position 2011

Adult Mouth Care in Iran - Category Analysis

HEADLINES

TRENDS

  • There are only two products on the official OTC list for this category - Povidone Iodine and Sodium Fluoride mouthwash. These products have not traditionally been popular in Iran. Although there have been many advertisements in recent years highlighting the advantages of mouthwashes for oral health on television and in the press, they did not have a direct impact on annual sales and instead mainly boosted sales of mouthwashes within beauty and personal care. Overall, OTC mouth care continues to lose sales share to beauty and cosmetic product alternatives.

SWITCHES

COMPETITIVE LANDSCAPE

  • Shahr Daru Laboratories, which produces its Sodium Fluoride mouth wash brand, continued to lead sales in 2011 with a retail value share of 47%. Strong competition from key beauty and personal care alternatives makes OTC suppliers reluctant to invest heavily in adult mouth care in Iran.

PROSPECTS

  • Adult mouth care sales will continue to decline over the forecast period, with a projected constant value CAGR decline of 8% - an improvement nevertheless on the review period CAGR decline of 22%. Overall, this category will continue to suffer from competition from beauty and personal care alternatives.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Iran - Category Analysis

HEADLINES

TRENDS

  • Due to the widespread consumption of RX analgesics products without prescription, consumption of analgesics is estimated to be much higher than the data projected in Euromonitor database (Euromonitor only covers OTC analgesics). It is common practice for Iranian consumers to obtain RX analgesics without prescription, even though, on paper, it is illegal. According to the Iranian Ministry of Health and Hygiene’s database, codeine acetaminophen (Rx) sales were almost two and a half times higher than the non-codeine variant (OTC) in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Tolid Daru led analgesics with 12% of value sales in 2011. However, Dr Abidi Pharmaceutical was a close second with 10% followed by Chemi Darou in third place with 8%. It is government policy to contact the companies at the start of the year and ascertain their production capacity and then divide the volume of production between them according to capacity. This is carried out because most of the main pharmaceutical companies in Iran are owned by the government.

PROSPECTS

  • Demand for analgesics is expected to grow in the Iranian market but the ability of domestic and multinational companies to respond to this demand is in serious doubt. Current growing sanctions on the Iranian economy, especially on the financial system, means that there will be many issues for importers when paying for the purchased products and also many problems for domestic manufacturers in importing raw materials. It is expected that importation of analgesics will become even more limited in the coming years due to sanctions. However, domestic production will survive due to the strong support of the Iranian government.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Iran - Category Analysis

TRENDS

  • No calming and sleeping products are currently on the Ministry of Health and Hygiene’s official OTC list. Consumption of UTC calming and sleeping products is rising rapidly due to on-going Westernisation and the increasingly stressful pace of modern life in Iran. However, there are no signs that the Ministry of Health and Hygiene has plans to add calming and sleeping products to its OTC list over the coming years.

Cough, Cold and Allergy (Hay Fever) Remedies in Iran - Category Analysis

HEADLINES

TRENDS

  • Coughs, colds and different forms of flu are widespread in Iran especially in the second half of the year when the weather is cold and dry in key urban areas, such as Tehran, Mashhad, Isfahan, Tabriz and Shiraz. Low levels of hygiene alongside self medication make cold related ailments a significant issue for most Iranian households. Adult Cold Tablet, which is a combination of phenylephrine, chlorpheniramine maleate and acetaminophen is a widely consumed product in this category and which accounted for 30% of value sales in 2011. The product has been offered under several brand names based on the name of the producer such as Cold Stop by Loghman Pharmaceutical & Hygienic, Coldax by Dr Abidi Pharmaceutical, Griphen by Tehran Darou Pharmacy, Relicol by Tolid Daru, Biolenol Cold by Bakhtar Bioshimi Pharmaceutical, Day Cold and Night Cold by Minoo Pharmaceutical, Exacold by Exir Pharmaceutical and Supracold by Amin Pharmaceutical.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dr Abidi Pharmaceutical was the leading company in cough, cold and allergy (hay fever) remedies in 2011 with 23% of value sales. In second position Kharazmi Pharmaceutical held a 9% share, followed by Pour Sina Pharmaceutical with 8% of value sales. Dr Abidi Pharmaceutical has a good reputation for OTC products among chemists/pharmacists and has a sound distribution network. The reason for its much higher share compared to other suppliers is the strong performance of its Adult Cold Tablet brand, which accounted for 60% of Dr Abidi Pharmaceutical’s value sales in cough, cold and allergy (hay fever) remedies.

PROSPECTS

  • It is not expected that the cough, cold and allergy (hay fever) remedies category will see many major changes over the forecast period. Sales are likely to advance by a CAGR of 11% in constant value terms. Cough remedies and antihistamines/allergy remedies will continue to be the more significant categories and extend their lead until 2016. Although the same categories will continue to dominate, such as cough remedies and adult cold remedies, newer categories, including decongestant rubs, will become more popular due to increased awareness promoted by the main producers.

CATEGORY DATA

  • Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Iran - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies witnessed many fluctuations in recent years. Several factors act paradoxically and determine consumption patterns of consumer health products. Major improvements in the quality of water as well as very tight controls on food services introduced by the government, both had a huge impact on controlling digestive diseases. However, rapid growth of food service outlets, especially in key urban areas, along with more hectic lifestyles, resulted in the popularity of eating food outside the home. In spite of the government’s tight controls, the risk of digestive ailments is much higher when dining out than it is when food is prepared at home. Furthermore, the popularity of loose unpackaged traditional products, as well as consumption of Rx without prescription, all work as a barrier for the further expansion of OTC digestive remedies in Iran. Overall this category saw 16% growth in current value terms in 2011 which was higher than the review period CAGR of 11%.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Alborz Darou led with an 18% value share followed by Loghman Pharmaceutical & Hygienic on 10% in digestive remedies. Aluminium/Magnesium/Simethicone SUSP was a very strategic product for both companies and its high consumption contributed heavily to their leadership in this category. Magnesium Hydroxide suspension, Bismuth Subcitrate and Digestive also saw high demand in digestive remedies. Many Iranian families keep these medicines in their homes and use them whenever they feel even a slight discomfort in their stomach.

PROSPECTS

  • Digestive remedies is expected to post a negative constant value CAGR of 3% over the forecast period, compared to a negative constant value CAGR of 6% over the review period, showing a major improvement. The reason for the negative constant growth stems from the subsidies which are paid on these products by the Iranian government, which precludes their growth in line with inflation.

CATEGORY DATA

  • Table 29 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 30 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 31 Digestive Remedies Company Shares 2007-2011
  • Table 32 Digestive Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Iran - Category Analysis

HEADLINES

TRENDS

  • Phenol Glycerin 6.4% is currently the only official OTC ear care product available in Iran. Whilst products introduced in Iran in 2006 recorded good growth during 2007 and 2008, sales have since slowed as a result of increasing category maturity. In 2011 this category saw current value growth of 22%, which was higher than the previous year but could not repeat significant rates of over 50% during its first few years on the market.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sepidach is the only supplier of Phenol Glycerin 6.4% in Iran and accounted for 100% of ear care retail value sales in 2011. The company offers good quality products and packaging and tries to ensure that its brands are available in pharmacies throughout the country.

PROSPECTS

  • Ear care has a projected forecast period constant retail value CAGR of 5%, partly because more Iranians are expected to use ear care products without a prescription and are instead increasingly likely to seek the advice of a pharmacist as opposed to a doctor before using these products.

CATEGORY DATA

  • Table 35 Sales of Ear Care: Value 2006-2011
  • Table 36 Sales of Ear Care: % Value Growth 2006-2011
  • Table 37 Ear Care Company Shares 2007-2011
  • Table 38 Ear Care Brand Shares 2008-2011
  • Table 39 Forecast Sales of Ear Care: Value 2011-2016
  • Table 40 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Iran - Category Analysis

TRENDS

  • No emergency contraceptive products are currently on the Ministry of Health and Hygiene’s official OTC list. However, as a result of on-going Westernisation and changing lifestyle trends, demand for emergency contraceptive products could grow rapidly during the forecast period. Young Iranians are increasingly looking for open relationships and premarital sex and will be the main consumer groups of these products over the coming years. However, it is unlikely that emergency contraceptive products will be placed on the official OTC list.

Eye Care in Iran - Category Analysis

HEADLINES

TRENDS

  • Only three products in eye care are included in the official OTC list from the Ministry of Health and Hygiene, namely Artificial Tears, Ophthalmic Bath Solution and Simple Eye Oint. Although other eye care products are not available OTC officially, consumers can buy and use them without a prescription in almost every chemist/pharmacy in Iran. However, consumption of eye care products without prescription is not usually the case.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sina Darou Laboratories remained the sole supplier of eye care products in Iran in 2011. The company benefits from its modern production line and its very strong distribution network, which enables it to cover almost every pharmacy in the country.

PROSPECTS

  • Eye care’s projected forecast period constant retail value CAGR of 4% will be very similar to the review period constant value CAGR. As there are no negative or positive factors likely to damage or boost sales of these products or dent the monopoly of Sina Darou Laboratories, consumption is expected to remain very similar to the review period

CATEGORY DATA

  • Table 41 Sales of Eye Care by Category: Value 2006-2011
  • Table 42 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 43 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 44 Standard Eye Care by Positioning 2007-2011
  • Table 45 Eye Care Company Shares 2007-2011
  • Table 46 Eye Care Brand Shares 2008-2011
  • Table 47 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 48 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Iran - Category Analysis

HEADLINES

TRENDS

  • Consumption of herbal remedies has a long history in Iran and famous people, such as Avicenna, were pioneers in this area. Attari outlets are traditionally very active in Iran and were the main outlets for sales of herbal medication. Since the introduction of modern medicine at the beginning of the 2000s, Attari stores became less important although they are still considered significant healthcare outlets, even in urban areas. Attaris offer a wide range of herbal medicines, usually in bulk/unpackaged format, and consumers can consult with the shopkeeper who usually knows a lot about traditional remedies.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is highly fragmented in Iran and due to strong competition from loose and unpackaged brands, major suppliers are reluctant to invest in the category. Although companies, such as Dineh Iran and Goldaru Pharmaceutical Laboratory, have started operating in recent years, they still only held negligible sales shares in 2011.

PROSPECTS

  • The future outlook for herbal/traditional products is not bright. Although the projected forecast period declining constant value CAGR of 3% will be higher than the review period CAGR decline of 4%, the category will continue to struggle against standard alternatives. Standard alternatives have wider distribution and more marketing activities which will hamper growth of herbal products in Iran.

CATEGORY DATA

  • Table 49 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 50 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 51 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 52 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Iran - Category Analysis

HEADLINES

TRENDS

  • Like many other consumer health categories, the official OTC list for skin care contains very few products while a large number of non-OTC alternatives exist in the market. These alternatives include many forms of hair loss treatments, which are classified as toiletries, to different forms of antifungals which are not OTC in Iran. This has resulted in relatively low value growth of consumer health medicated skin care in recent years. The category saw current value growth of 13% in 2011 which was very similar to the review period CAGR at 12%, while in reality consumption for medicated skin care OTC and RX has increased significantly due to greater awareness of these products among consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Tolid Daru was the leader in medicated skin care in 2011 with a 17% share of value sales. It was followed by Pak Darou with 14% and Behsa with 11%. The main reason for the relatively high value share of Tolid Daru is its high production of Povidone Iodine 10% in 250ml size, which is consumed widely in hospitals and clinics as topical germicidals/antiseptics.

PROSPECTS

  • Sales of medicated skin care are projected to decline by a CAGR of 4% over the forecast period, representing a slight improvement on the 5% CAGR decline during the review period. Consumers will continue to visit their doctors for many skin problems, which will negatively impact sales.

CATEGORY DATA

  • Table 53 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 54 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 55 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 56 Medicated Skin Care Brand Shares 2008-2011
  • Table 57 Hair Loss Treatments Brand Shares 2008-2011
  • Table 58 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Iran - Category Analysis

TRENDS

  • Sales of NRT smoking cessation aids sales remained marginal in Iran at the end of the review period. A small quantity of such products is imported into the country in order to satisfy demand amongst a very small number of high income earners. However, demand remains negligible amongst low and middle income demographics due to the high price of NRT smoking cessation aids and a lack of consumer awareness.

Sports Nutrition in Iran - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition products witnessed increased demand at the end of the review period as health awareness, particularly among more affluent urbanites, increased. The 54% current value growth in 2011 was higher than the review period CAGR of 34%, largely because a greater variety of products entered the market and a particular segment of the Iranian population (namely urban males) became more familiar with them.

COMPETITIVE LANDSCAPE

  • Sports nutrition remains highly fragmented, with no supplier dominating sales. Most products currently available originate from the US and Canada. Contraband products are also common with products usually coming in from the Iraqi and Turkish borders.

PROSPECTS

  • Sports nutrition sales are expected to grow over the forecast period, at a constant value CAGR of 14%, compared to a CAGR of 13% in constant terms for the review period. This would indicate that the category will perform better largely due to increased health awareness and a focus on fitness in urban areas.

CATEGORY DATA

  • Table 60 Sales of Sports Nutrition: Value 2006-2011
  • Table 61 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 62 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 63 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Iran - Category Analysis

HEADLINES

TRENDS

  • Demand for vitamins and dietary supplements sustained healthy growth in 2011. In spite of many restrictions regarding importing products into Iran due to international sanctions, vitamins and dietary supplements by multinational companies continued to flood into nearly all of the 7,000 pharmacies in Iran. Most Iranians suffer from lack of many necessary vitamins and dietary supplements in their regular diet which causes many health problems, especially when they reach their 30s. The situation is even worse for women who are the main sufferers of problems such as osteoporosis. Many multinationals understood this opportunity and started importing their products into the country from the early 2000s. This, coupled with health programmes to increase awareness among doctors and health care specialists, boosted prescription sales of vitamins and dietary supplements. Iran is rapidly converting from an immature to a more developed market with more sophisticated products and this trend accelerated in 2011 with wider distribution of new categories, such as specific products for men and pregnant women.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Poura Teb Medical & Pharmaceutical and Elm Pharmad Gostar are the main importers in this category and led sales in 2011 with value shares of 28% and 7% respectively. Poura Teb Medical & Pharmaceutical is a solo importer and distributor of Nature Made, 21th Century, Alpex Pharma, Arnet Pharmaceutical, Vitabiotics, GFR Pharma, Prolab Nutrition, Kendy Pharma/SupraVit and Natural Organics/Nature’s Plus. Elm Pharmad Gostar is mainly active in the importation of well known multivitamin, Pharmaton which is produced by Boehringer Ingelheim.

PROSPECTS

  • Vitamins and dietary supplements is expected to continue its high growth during the forecast period due to an increase in demand among young Iranians who are expected to demonstrate higher awareness of these products over the forecast period, thanks to the activities of key suppliers in pharmacies and healthcare offices (detailing programmes for the doctors). Overall, vitamins and dietary supplements is expected to register a CAGR of 2% in constant terms over the forecast period, up from a CAGR of 1% in constant terms over the previous five years.

CATEGORY DATA

  • Summary 10 Dietary Supplements Brand Ranking by Positioning 2011
  • Table 64 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 65 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 66 Dietary Supplements by Positioning 2007-2011
  • Table 67 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 68 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 69 Vitamins Brand Shares 2008-2011
  • Table 70 Dietary Supplements Brand Shares 2008-2011
  • Table 71 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 72 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Iran - Category Analysis

HEADLINES

TRENDS

  • Obesity is becoming a serious issue in Iran, the rate of which has grown rapidly in recent years. While in 2008 some 26.3% of the population were obese (39.5% of women and 14.5% of men), the Ministry of Health recently announced that the rate has grown to more than 30% in 2011. The main reason for this rapid growth is the rapid change in lifestyle, even in rural areas, which has resulted in less physical activity, an unhealthy diet (such as fast foods) and inappropriate eating habits (such as eliminating breakfast). These cultural changes have acted as a key motive for the growth of weight loss supplements in Iran. Overall, this category achieved current value growth of 28% in 2011, which was much higher than the review period CAGR of 22% and highlights the steady growth in demand.

COMPETITIVE LANDSCAPE

  • Poura Teb Medical & Pharmaceutical led sales within the highly fragmented weight management category in 2011, recording a retail value share of 15%. The company’s success can be attributed to the popularity of its Fiber Clear brand. Poura Teb Medical & Pharmaceutical is also the leading importer of vitamins and dietary supplements in Iran and benefits from its wide range of products from leading multinationals, such as Pharmaton, Kendy, and 21st Century. Furthermore, the company has a good distribution network and invests in advertising within most leading Iranian pharmacies.

PROSPECTS

  • Weight management is expected to post a constant value CAGR of 6% over the forecast period. Sales will continue to be comprised solely of weight loss supplements. This CAGR will be higher than the 4% CAGR registered over the review period. Sales over the forecast period will be boosted by increasingly hectic lifestyles with people having less time to cook for themselves and increased exposure to Western media and culture that appears to venerate the thin and waif-like female form.

CATEGORY DATA

  • Table 73 Sales of Weight Management by Category: Value 2006-2011
  • Table 74 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 75 Weight Management Company Shares 2007-2011
  • Table 76 Weight Management Brand Shares 2008-2011
  • Table 77 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 78 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Iran - Category Analysis

HEADLINES

TRENDS

  • There was little change within wound care during the course of the review period, with sales continuing to be dominated by existing products with non-attractive packaging and suppliers making no significant effort to introduce new innovative brands.

COMPETITIVE LANDSCAPE

  • Bandhaye Pezeshki and Abzar Darman led wound care sales in 2011, recording respective retail value shares of 18% and 17%. The only other major player in the category is Kaveh Bandage Gauze & Hydrophile Cotton, which recorded a retail value share of 11%, with “others” holding the remaining 54% of retail value sales.

PROSPECTS

  • Wound care sales will benefit in the coming years from the marketing activities of major manufacturers, increased production, and improved distribution. However, constant retail value sales are projected to decline by a CAGR of 2% over the forecast period due to tight controls on unit price from the government which stops manufacturers from increasing their prices in line with inflation.

CATEGORY DATA

  • Table 79 Sales of Wound Care by Category: Value 2006-2011
  • Table 80 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 81 Wound Care Company Shares 2007-2011
  • Table 82 Wound Care Brand Shares 2008-2011
  • Table 83 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 84 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!